Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6

BACKGROUND: Pegylated interferon alpha 2a, alpha 2b and ribavirin have been included to the National List of Essential Medicines (NLEM) for treatment of only chronic hepatitis C genotypes 2 and 3 in Thailand. This reimbursement policy has not covered for other genotypes of hepatitis C virus infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapol, Nattiya, Lochid-amnuay, Surasit, Teerawattananon, Yot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974770/
https://www.ncbi.nlm.nih.gov/pubmed/27492396
http://dx.doi.org/10.1186/s12876-016-0506-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974770/
https://www.ncbi.nlm.nih.gov/pubmed/27492396
http://dx.doi.org/10.1186/s12876-016-0506-4

Ejemplares similares